Abiopharma

PureTech Founded Entity Celea Therapeutics to Deliver Two Presentations at the Upcoming European Respiratory Society (ERS) Congress

Celea Therapeutics Will Present Phase 3 Trial Design for Idiopathic Pulmonary Fibrosis and Key Insights from a Deupirfenidone Drug-Drug Interaction Study at the Upcoming European Respiratory Society (ERS) Congress

Notice of special meeting for 27.9.26 – approval of a one-time grant to Mr. Rafi Amit, voting ballot

Update regarding the issuance process of the held company in China - continues to work to promote obtaining approval from the Securities Authority in China

Subsidiary financial report publication

An investors’ call to review the results and developments in the company will be held on 27.8.26 at 11:00. The reports as of 30.6.26 will be published no later than 27.8.26.

Events and transactions

Change in Rafi Amit’s holdings in the held company Camtek

Update regarding the issuance process of the held company in China - on 16.7.26 the listing committee of the Shenzhen Stock Exchange will hold a discussion regarding approval of the Access prospectus

Holdings of interested parties/officers as of 30.6.26 - periodic report amendment